霍奇金淋巴瘤:专注于不断发展的治疗模式
Joseph L Roswarski1, Dan L Longo2
1Division of Hematology and Oncology, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC, USA.
Best practice & research. Clinical haematology
|December 13, 2023
概括
霍奇金淋巴瘤 (HL) 是一种可治愈的B细胞癌症. 像布伦图西马布维多丁和检查点抑制剂这样的新疗法正在改变HL治疗,但需要进一步的研究来优化它们在所有疾病阶段的使用.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 霍奇金淋巴瘤 (HL) 是一种源自生殖中心细胞的B细胞恶性瘤.
- HL是一种血液性恶性瘤,严重依赖免疫微环境.
- 在HL中的新生细胞采用免疫逃生机制,特别是通过调高编程死亡连接体.
研究的目的:
- 为了解决关于最佳霍奇金淋巴瘤管理的缺乏共识,特别是在有限阶段的疾病中.
- 评估新药,包括布伦图西马布维多丁和检查点抑制剂,对HL治疗环境的影响.
- 引导未来的研究将这些新型药物纳入HL的各个阶段.
主要方法:
- 对霍奇金淋巴瘤当前治疗策略的审查.
- 分析免疫微环境和免疫逃脱在HL病变发生中的作用.
- 评估关于布伦图西马布维多丁和检查点抑制剂在HL管理中的新兴数据.
主要成果:
- 霍奇金淋巴瘤是高度可治愈的,但最佳的管理策略仍在争论中.
- 布伦图西马布维多丁和检查点抑制剂在HL治疗中取得了重大进展.
- 由于这些新型药物,HL的当前治疗环境正在迅速发展.
结论:
- 进一步的研究对于将布伦图西马布维多丁 (brentuximab vedotin) 和检查点抑制剂等新药整合到霍奇金淋巴瘤治疗的所有阶段至关重要.
- 研究应该集中在确定前线治愈率的改善和与这些药物相关的长期毒性.
- 优化新疗法的使用对于提高治愈率和尽量减少霍奇金淋巴瘤患者的毒性至关重要.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.8K
相关概念视频
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:30Cancer Vaccines
376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K